Abstract: The invention relates to compounds of Formula I: and pharmaceutically acceptable salts and prodrugs thereof, wherein R1, R2, and R3 are defined as set forth in the specification. The compounds are agonists of neurotrophin (such as nerve growth factor) receptors.
Type:
Grant
Filed:
September 9, 2016
Date of Patent:
October 23, 2018
Assignees:
BIONURE FARMA, S.L., INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (IDIBAPS), CONSEJO SUPERIOR DE INVESTIGACIONS CIENTIFICAS (CSIC)